Biocon subsidiary acquires research facility from Pfizer Healthcare

September 24, 2019 10:43

Biotechnology major Biocon on Tuesday said its subsidiary has acquired a Chennai-based biological research facility from Pfizer Healthcare for an undisclosed amount. Biocon Biologics has acquired research and development (R&D) capital assets of a 60,000-square feet research facility at Ticel Bio Park in Chennai, Biocon said in a statement.

"The high-end integrated R&D facility in Chennai will enable Biocon Biologics to expand its R&D capability and accelerate its journey towards meeting its strategic long-term goal of addressing the needs of millions of patients worldwide," Biocon Biologics CEO Christiane Hamacher said. This investment will allow the company to fast-forward development of its biosimilars from lab to pilot scale, he added. -- PTI

« Back to LIVE

TOP STORIES

Here's what EC has to say on delay in voter turnout figures

This is for the first time the EC has officially come out with a statement on allegations of delay in sharing turnout data.

Ex-Delhi batter Milind in USA squad for T20 World Cup

Milind Kumar played seven seasons for Delhi in Ranji Trophy along with stints for Sikkim and Tripura before he migrated to the US in search of better opportunities.

West Indies pacer Joseph gets surprise call-up for T20 World Cup

Shamar Joseph has only played three T20 matches in franchise-based leagues and has not taken a wicket.

IPL PIX: Bumrah on fire as MI limit KKR to 169

Images from the IPL 2024 match between Mumbai Indians and Kolkata Knight Riders.

Rohith Vemula not a Dalit, he ended life because....: Police closure report

The Cyberabad police that investigated the case informed the court that Rohith Vemula did not belong to Scheduled Caste and that he was aware of it.